Latest filing published 13 Feb 2026 for Coeptis Therapeutics Holdings, Inc., €883k.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Filings by David Mehalick span 2 companies, the busiest being Z Squared Inc. and Coeptis Therapeutics Inc. In total, 7 filings cover trades dated from 16 November 2021 to 11 February 2026.
Market trades split into 3 purchases (€15k) and 1 sale. No amount is published for 1 filing, which the totals therefore leave out. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 1 share grant and 1 option exercise.
In size, the median ticket on the buying side is €3,674. 3 out of 3 purchases came within 30 days of a purchase by at least one other insider of the same company. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.
The record was last updated on 13 February 2026 with a share grant in Z Squared Inc. The latest purchase dates back some time: it was published 1,020 days ago, on 9 January 2024. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations